Nationwide Fund Advisors’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-149
| Closed | -$208K | – | 835 |
|
|
2017
Q3 | $208K | Hold |
149
| – | – | ﹤0.01% | 2623 |
|
|
2017
Q2 | $166K | Sell |
149
-70
| -32% | -$78K | ﹤0.01% | 2705 |
|
|
2017
Q1 | $119K | Hold |
219
| – | – | ﹤0.01% | 2785 |
|
|
2016
Q4 | $134K | Hold |
219
| – | – | ﹤0.01% | 2773 |
|
|
2016
Q3 | $157K | Hold |
219
| – | – | ﹤0.01% | 2737 |
|
|
2016
Q2 | $159K | Buy |
219
+61
| +39% | +$44.3K | ﹤0.01% | 2716 |
|
|
2016
Q1 | $94K | Hold |
158
| – | – | ﹤0.01% | 2844 |
|
|
2015
Q4 | $90K | Hold |
158
| – | – | ﹤0.01% | 2881 |
|
|
2015
Q3 | $88K | Hold |
158
| – | – | ﹤0.01% | 2932 |
|
|
2015
Q2 | $125K | Sell |
158
-62
| -28% | -$49.1K | ﹤0.01% | 2941 |
|
|
2015
Q1 | $183K | Hold |
220
| – | – | ﹤0.01% | 2735 |
|
|
2014
Q4 | $158K | Hold |
220
| – | – | ﹤0.01% | 2749 |
|
|
2014
Q3 | $152K | Hold |
220
| – | – | ﹤0.01% | 2823 |
|
|
2014
Q2 | $185K | Buy |
220
+33
| +18% | +$27.8K | ﹤0.01% | 2789 |
|
|
2014
Q1 | $305K | Buy |
+187
| New | +$305K | ﹤0.01% | 2300 |
|